CD4 and meningeal tuberculosis: Based on this study, the Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America recommended that patients with TBM should not start ART within eight weeks after anti-tuberculosis treatment initiation, regardless of CD4 count [43].